P46 Drivers of Health Technology Assessment Methods and Process Reforms: An International Comparison of Real World Evidence, Patient Involvement and Discounting

Our research aims to understand what drives change in Health Technology Assessment (HTA) agencies ’ methods and processes (M&P), specifically positions on real-world evidence (RWE), patient involvement in HTA, and discounting, in Australia, Belgium, Canada, Denmark, England, France, Germany, Italy, Portugal, Sweden, Singapore, Spain, Taiwan, and the Netherlands.

Source: Value in Health - December 1, 2023 Category: International Medicine & Public Health Authors: E. Bell, P. Cubi-Molla, M. Garau, G. Kumar, J. Pan, P. Radu, C. Baxter, R. Gilardino, M. Goodall, K. Nelson, J. van Bavel Source Type: research